Trial Profile
Feasibility study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Jul 2011 New trial record